DTC Advertising’s Blurred Line: Rx Spots Look A Lot Like OTC Promotions
This article was originally published in The Tan Sheet
Executive Summary
Competition in the heartburn/GERD category between prescription and OTC drugs illustrates the increasing similarities between over-the-counter and Rx direct-to-consumer advertising
You may also be interested in...
Prilosec OTC Making Inroads Into Abbott’s Prevacid
Abbott Labs plans to counter the launch of Prilosec OTC with a broad direct-to-consumer advertising campaign for its Rx proton pump inhibitor Prevacid
DTC Ad Endorsement Policy Should Be Consistent With OTC Practice – FTC
Endorsements and testimonials in direct-to-consumer advertising for prescription drugs should be subject to the same standards the Federal Trade Commission applies to OTC drug ads, FTC advises in Dec. 1 comments to the agency
GSK Flonase Switch Application Coming? Actual-Use Study Underway
GlaxoSmithKline is actively considering the switch potential for Flonase with a trial evaluating consumers' ability to use the allergy nasal spray appropriately, according to the firm